Oslo, Norway, 25 February 2014.
Please find attached the presentation and report for Q4 2013 and preliminary full year 2013. The presentation will be held the 25 February at 0800 at Felix konferansesenter.
Kind regards,
Per Walday
CEO
Email: pw@pcibiotech.no
Mobil: +47 917 93 429
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
